266. Familial mediterranean fever Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 28 / Drugs : 22 - (DrugBank : 5) / Drug target genes : 14 - Drug target pathways : 59
Familial mediterranean fever and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 266 | Familial mediterranean fever |
| 46 | Malignant rheumatoid arthritis |
| 56 | Behcet disease |
| 51 | Scleroderma |
| 49 | Systemic lupus erythematosus |
| 2 | Amyotrophic lateral sclerosis |
| 28 | Systemic amyloidosis |
| 34 | Neurofibromatosis |
| 65 | Primary immunodeficiency |
| 85 | Idiopathic interstitial pneumonia |
| 42 | Polyarteritis nodosa |
| 331 | Idiopathic multicentric castleman disease |
| 210 | Single Ventricle |
| 93 | Primary biliary cholangitis |
| 26 | HTLV-1-associated myelopathy |
| 106 | Cryopyrin-associated periodic syndrome |
| 50 | Dermatomyositis |
| 107 | Juvenile idiopathic arthritis |
| 84 | Sarcoidosis |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 41 | Giant cell arteritis |
| 108 | TNF receptor-associated periodic syndrome |
| 267 | Hyper-IgD syndrome |
| 54 | Adult still disease |